Cardiol Therapeutics Growth Metrics (2021-2026) | CRDL

Growth Metrics Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) -518.70%-107.60%-120.75%34.18%38.07%39.45%39.82%41.43%42.05%47.51%61.49%14.68%23.44%25.23%27.47%29.84%-24.31%
Enterprise Value Growth (3y) (Quarter) -33.61%12.94%20.02%30.97%34.99%38.06%44.81%29.49%17.99%
Enterprise Value Growth (5y) (Quarter) -7.38%
Enterprise Value (QoQ) (Quarter) 14.49%-192.42%11.23%6.48%9.07%12.81%16.48%8.56%9.62%15.15%17.36%17.17%33.70%-87.99%25.84%19.11%35.69%-81.85%-31.40%
Interest Coverage Ratio Growth (1y) (Quarter) -17.80%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Assets Growth (3y) (Quarter) 1.000.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 3,482.00438.00-1554.001,878.00
Return on Capital Employed Growth (3y) (Quarter) -14065.00
Return on Capital Employed (QoQ) (Quarter) 2,846.002,642.00-1085.00-921.00-198.00